Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie Tabiasco

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Proceedings of the National Academy of Sciences of the United States of America|December 18, 2002
Engagement of CD160 receptor by HLA-C is a triggering mechanism used by circulating natural killer (NK) cells to mediate cytotoxicityPhilippe Le Bouteiller, Aliz Barakonyi, Jérome Giustiniani, et al.
Oncoimmunology|September 14, 2016
The ecto-ATPDase CD39 is involved in the acquisition of the immunoregulatory phenotype by M-CSF-macrophages and ovarian cancer tumor-associated macrophages: Regulatory role of IL-27Sènan M d'Almeida, Gilles Kauffenstein, Charlotte Roy, et al.
Purinergic Signalling|December 14, 2017
Loss of vascular expression of nucleoside triphosphate diphosphohydrolase-1/CD39 in hypertensionCharlotte Roy, Julie Tabiasco, Antoine Caillon, et al.
Journal for Immunotherapy of Cancer|June 26, 2020
Involvement of the M-CSF/IL-34/CSF-1R pathway in malignant pleural mesotheliomaThibaut Blondy, Sènan Mickael d'Almeida, Tina Briolay, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 21, 2008
Critical and differential roles of NKp46- and NKp30-activating receptors expressed by uterine NK cells in early pregnancyHicham El Costa, Audrey Casemayou, Maryse Aguerre-Girr, et al.
Reproductive Biomedicine Online|March 21, 2009
Soluble HLA-G in IVF/ICSI embryo culture supernatants does not always predict implantation success: a multicentre studyJulie Tabiasco, Sophie Perrier d'Hauterive, Fabienne Thonon, et al.
The Journal of Experimental Medicine|April 13, 2011
A novel antiangiogenic and vascular normalization therapy targeted against human CD160 receptorSophie Chabot, Nabila Jabrane-Ferrat, Karine Bigot, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Proceedings of the National Academy of Sciences of the United States of America|December 18, 2002
Engagement of CD160 receptor by HLA-C is a triggering mechanism used by circulating natural killer (NK) cells to mediate cytotoxicityPhilippe Le Bouteiller, Aliz Barakonyi, Jérome Giustiniani, et al.
Oncoimmunology|September 14, 2016
The ecto-ATPDase CD39 is involved in the acquisition of the immunoregulatory phenotype by M-CSF-macrophages and ovarian cancer tumor-associated macrophages: Regulatory role of IL-27Sènan M d'Almeida, Gilles Kauffenstein, Charlotte Roy, et al.
Purinergic Signalling|December 14, 2017
Loss of vascular expression of nucleoside triphosphate diphosphohydrolase-1/CD39 in hypertensionCharlotte Roy, Julie Tabiasco, Antoine Caillon, et al.
Journal for Immunotherapy of Cancer|June 26, 2020
Involvement of the M-CSF/IL-34/CSF-1R pathway in malignant pleural mesotheliomaThibaut Blondy, Sènan Mickael d'Almeida, Tina Briolay, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 21, 2008
Critical and differential roles of NKp46- and NKp30-activating receptors expressed by uterine NK cells in early pregnancyHicham El Costa, Audrey Casemayou, Maryse Aguerre-Girr, et al.
Reproductive Biomedicine Online|March 21, 2009
Soluble HLA-G in IVF/ICSI embryo culture supernatants does not always predict implantation success: a multicentre studyJulie Tabiasco, Sophie Perrier d'Hauterive, Fabienne Thonon, et al.
The Journal of Experimental Medicine|April 13, 2011
A novel antiangiogenic and vascular normalization therapy targeted against human CD160 receptorSophie Chabot, Nabila Jabrane-Ferrat, Karine Bigot, et al.
Pageof 4